{
    "clinical_study": {
        "@rank": "115916", 
        "arm_group": [
            {
                "arm_group_label": "Low-frequency (1 Hz) rTMS", 
                "arm_group_type": "Active Comparator", 
                "description": "Low-frequency active stimulation over the right DLPFC on 5 consecutive days every week for 2 weeks, for a total of 10 therapy sessions, with 37.5 minutes per session."
            }, 
            {
                "arm_group_label": "High-frequency (10 Hz) rTMS", 
                "arm_group_type": "Active Comparator", 
                "description": "High-frequency active stimulation over the right DLPFC on 5 consecutive days every week for 2 weeks, for a total of 10 therapy sessions, with 37.5 minutes per session."
            }, 
            {
                "arm_group_label": "Sham rTMS", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Sham stimulation over the right DLPFC on 5 consecutive days every week for 2 weeks, for a total of 10 therapy sessions, with 37.5 minutes per session."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the effects of repetitive transcranial magnetic\n      stimulation (rTMS) in civilian patients with a confirmed diagnosis of post-traumatic stress\n      disorder (PTSD). This research study will determine whether low-frequency (1 Hertz [Hz]) or\n      high-frequency (10 Hz) rTMS over the right dorsolateral prefrontal cortex (DLPFC) has an\n      effect on symptoms of PTSD compared to sham rTMS treatment."
        }, 
        "brief_title": "rTMS in the Treatment of PTSD", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Post-traumatic Stress Disorder (PTSD)", 
        "condition_browse": {
            "mesh_term": [
                "Stress Disorders, Post-Traumatic", 
                "Stress Disorders, Traumatic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  primary diagnosis of PTSD as determined by a structured interview using the Mini\n             International Neuropsychiatric Interview (MINI)\n\n          -  no change in psychotropic medications within 4 weeks before the start of rTMS\n\n          -  age > 19 years and < 70 years\n\n          -  competency to give informed consent\n\n        Exclusion Criteria:\n\n          -  any non-fixed metal object or implant (including cochlear implants) in brain, skull,\n             scalp, or neck within 30 cm of the magnetic rTMS coil\n\n          -  implantable devices, including cardiac pacemakers and defibrillators\n\n          -  other contraindications to rTMS, including history of seizures (except childhood\n             febrile seizures) or recent and unexplained syncope, first-degree relative with a\n             history of epilepsy, treatment with a medication known to substantially decrease the\n             seizure threshold, or pregnancy\n\n          -  psychiatric diagnoses of psychosis or psychotic disorder (including psychotic\n             depression), bipolar type I disorder, or organic mental disorders\n\n          -  substance abuse/dependence within the past 3 months\n\n          -  active suicidal risk as judged by the clinician\n\n          -  borderline or antisocial personality disorder\n\n          -  acute medical illness, including cancer\n\n          -  any significant central nervous system disorder, such as brain mass, stroke, etc."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01806168", 
            "org_study_id": "H12-01578", 
            "secondary_id": "V12-01578"
        }, 
        "intervention": {
            "arm_group_label": [
                "Low-frequency (1 Hz) rTMS", 
                "High-frequency (10 Hz) rTMS", 
                "Sham rTMS"
            ], 
            "description": "Magstim Super Rapid-2", 
            "intervention_name": "rTMS", 
            "intervention_type": "Device", 
            "other_name": "repetitive transcranial magnetic stimulation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Post-traumatic stress disorder", 
            "Repetitive transcranial magnetic stimulation", 
            "Civilians", 
            "Neurostimulation", 
            "Dorsolateral prefrontal cortex"
        ], 
        "lastchanged_date": "March 21, 2014", 
        "link": {
            "description": "Transcranial Magnetic Stimulation (TMS) Clinic", 
            "url": "http://psychiatry.vch.ca/tms.htm"
        }, 
        "location": {
            "contact": {
                "email": "mario.mckenna@vch.ca", 
                "last_name": "Mario McKenna", 
                "phone": "604-875-4111", 
                "phone_ext": "62410"
            }, 
            "facility": {
                "address": {
                    "city": "Vancouver", 
                    "country": "Canada", 
                    "state": "British Columbia", 
                    "zip": "V5Z 1M9"
                }, 
                "name": "Vancouver General Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Larry Ong, MD, FRCPC", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Michael Wilkins-Ho, MD, FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Peter Chan, MD, FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Hiram Mok, MD, FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Raymond W Lam, MD, FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Richard Singleton, MSW", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Calla Finley, MSW", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gary Alward, MSW", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Mario McKenna, MHA, MSc", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fidel Vila-Rodriguez, MD, FRCPC", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Role of Fast or Slow Repetitive Transcranial Magnetic Stimulation as Adjunct Therapy in Civilian Post-Traumatic Stress Disorder", 
        "other_outcome": {
            "measure": "Neuropsychological testing", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to endpoint (Week 2)"
        }, 
        "overall_official": {
            "affiliation": "Vancouver Coastal Health", 
            "last_name": "Larry Ong, MD, FRCPC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The PCL is a standardized self-report rating scale for PTSD comprising 17 items that correspond to the key symptoms of PTSD.", 
            "measure": "PTSD Checklist -- Civilian Version (PCL-C)", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to endpoint (Week 2)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01806168"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Hamilton Depression Rating Scale, 17-item version (HAMD-17)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to endpoint (Week 2)"
            }, 
            {
                "measure": "Quick Inventory of Depressive Symptomatology -- Self-Report (QIDS-SR)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to endpoint (Week 2)"
            }, 
            {
                "measure": "Beck Anxiety Inventory (BAI)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to endpoint (Week 2)"
            }, 
            {
                "measure": "Generalized Anxiety Disorder (GAD-7) Scale", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to endpoint (Week 2)"
            }, 
            {
                "measure": "Clinician-Administered PTSD Scale for DSM-IV (CAPS)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to endpoint (Week 2)"
            }
        ], 
        "source": "University of British Columbia", 
        "sponsors": {
            "collaborator": {
                "agency": "Vancouver Coastal Health", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of British Columbia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}